Stock listing
Perseus Proteomics, Inc.
Selected listing: 4882 · TSE · JPY · JP
Perseus Proteomics, Inc. (Tokyo:4882), Health Technology. Latest release Aug 13, 2026: Non-consolidated Financial Results for the Three Months Ended June 30…
- Ticker
- Tokyo:4882
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Perseus Proteomics, Inc.
Perseus Proteomics, Inc. is a public company listed under the ticker 4882 in the Japanese market. Perseus Proteomics focuses on advancements in proteomics, contributing to the field of biotechnology.
Latest news from Perseus Proteomics, Inc.
Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
August 13, 2026
Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera
July 1, 2026
(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”
June 21, 2026
Perseus Proteomics : Non-consolidated Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023
August 12, 2022
Perseus Proteomics : Notice on Determination of Stock Option (Share acquisition rights) Details
July 11, 2022
Research Perseus Proteomics, Inc.
Perseus Proteomics, Inc. company profile
View the public company page for Perseus Proteomics, Inc. on 6ix.
Perseus Proteomics, Inc. news
Read company news and market updates connected to Perseus Proteomics, Inc..
Perseus Proteomics, Inc. investor events
Find investor webinars, events, and replay context for Perseus Proteomics, Inc..